These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 15187150

  • 21. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K, Cheng S, Martel-Pelletier J, Afif H, Pelletier JP, Li X, Ranger P, Fahmi H.
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [Abstract] [Full Text] [Related]

  • 22. Electrophilic lipid mediator 15-deoxy-Δ12,14-prostaglandin j2 modifies glucocorticoid signaling via receptor SUMOylation.
    Paakinaho V, Kaikkonen S, Levonen AL, Palvimo JJ.
    Mol Cell Biol; 2014 Sep; 34(17):3202-13. PubMed ID: 24980431
    [Abstract] [Full Text] [Related]

  • 23. Activation of the mouse heme oxygenase-1 gene by 15-deoxy-Delta(12,14)-prostaglandin J(2) is mediated by the stress response elements and transcription factor Nrf2.
    Gong P, Stewart D, Hu B, Li N, Cook J, Nel A, Alam J.
    Antioxid Redox Signal; 2002 Apr; 4(2):249-57. PubMed ID: 12006176
    [Abstract] [Full Text] [Related]

  • 24. 15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma.
    Raman P, Kaplan BL, Thompson JT, Vanden Heuvel JP, Kaminski NE.
    Mol Pharmacol; 2011 Jul; 80(1):201-9. PubMed ID: 21511917
    [Abstract] [Full Text] [Related]

  • 25. 15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.
    Nakata S, Yoshida T, Shiraishi T, Horinaka M, Kouhara J, Wakada M, Sakai T.
    Mol Cancer Ther; 2006 Jul; 5(7):1827-35. PubMed ID: 16891469
    [Abstract] [Full Text] [Related]

  • 26. Feedback control of cyclooxygenase-2 expression through PPARgamma.
    Inoue H, Tanabe T, Umesono K.
    J Biol Chem; 2000 Sep 08; 275(36):28028-32. PubMed ID: 10827178
    [Abstract] [Full Text] [Related]

  • 27. 15-deoxy-(Delta12,14)-prostaglandin J2 (15d-PGJ2) induces cell death through caspase-independent mechanism in A172 human glioma cells.
    Cho WH, Choi CH, Park JY, Kang SK, Kim YK.
    Neurochem Res; 2006 Oct 08; 31(10):1247-54. PubMed ID: 17006759
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes.
    Fionda C, Nappi F, Piccoli M, Frati L, Santoni A, Cippitelli M.
    Mol Pharmacol; 2007 Nov 08; 72(5):1246-57. PubMed ID: 17673570
    [Abstract] [Full Text] [Related]

  • 29. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells.
    Emi M, Maeyama K.
    Biochem Pharmacol; 2004 Apr 01; 67(7):1259-67. PubMed ID: 15013841
    [Abstract] [Full Text] [Related]

  • 30. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification.
    Kalantari P, Narayan V, Henderson AJ, Prabhu KS.
    FASEB J; 2009 Aug 01; 23(8):2366-73. PubMed ID: 19299483
    [Abstract] [Full Text] [Related]

  • 31. 15-deoxy-Delta12,14-prostaglandin J2 negatively regulates rankl gene expression in activated T lymphocytes: role of NF-kappaB and early growth response transcription factors.
    Fionda C, Nappi F, Piccoli M, Frati L, Santoni A, Cippitelli M.
    J Immunol; 2007 Apr 01; 178(7):4039-50. PubMed ID: 17371958
    [Abstract] [Full Text] [Related]

  • 32. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells.
    Raman P, Kaplan BL, Kaminski NE.
    J Pharmacol Exp Ther; 2012 Sep 01; 342(3):816-26. PubMed ID: 22700433
    [Abstract] [Full Text] [Related]

  • 33. Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions.
    Ueki S, Kato H, Kobayashi Y, Ito W, Adachi T, Nagase H, Ohta K, Kayaba H, Chihara J.
    Int Arch Allergy Immunol; 2007 Sep 01; 143 Suppl 1():15-22. PubMed ID: 17541271
    [Abstract] [Full Text] [Related]

  • 34. Streptozotocin-pancreatic damage in the rat: modulatory effect of 15-deoxy delta12,14-prostaglandin j(2) on nitridergic and prostanoid pathway.
    González E, Jawerbaum A, Sinner D, Pustovrh C, White V, Capobianco E, Xaus C, Peralta C, Roselló-Catafau J.
    Nitric Oxide; 2002 Mar 01; 6(2):214-20. PubMed ID: 11890746
    [Abstract] [Full Text] [Related]

  • 35. Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy.
    Winnett G, van Hagen D, Schrey M.
    Int J Cancer; 2003 Feb 20; 103(5):600-5. PubMed ID: 12494466
    [Abstract] [Full Text] [Related]

  • 36. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits angiotensin II-induced fibronectin expression via hepatocyte growth factor induction in human peritoneal mesothelial cells.
    Yokoyama Y, Masaki T, Kiribayashi K, Nakashima A, Kokoroishi K, Ogawa T, Kohno N, Yorioka N.
    Ther Apher Dial; 2010 Feb 20; 14(1):43-51. PubMed ID: 20438519
    [Abstract] [Full Text] [Related]

  • 37. 15-deoxy-delta-12-14-PGJ2 regulates apoptosis induction and nuclear factor-kappaB activation via a peroxisome proliferator-activated receptor-gamma-independent mechanism in hepatocellular carcinoma.
    Okano H, Shiraki K, Inoue H, Yamanaka Y, Kawakita T, Saitou Y, Yamaguchi Y, Enokimura N, Yamamoto N, Sugimoto K, Murata K, Nakano T.
    Lab Invest; 2003 Oct 20; 83(10):1529-39. PubMed ID: 14563954
    [Abstract] [Full Text] [Related]

  • 38. Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages.
    Janabi N.
    J Immunol; 2002 May 01; 168(9):4747-55. PubMed ID: 11971025
    [Abstract] [Full Text] [Related]

  • 39. 15d-PGJ2 inhibits oxidized LDL-induced macrophage proliferation by inhibition of GM-CSF production via inactivation of NF-kappaB.
    Matsuo T, Matsumura T, Sakai M, Senokuchi T, Yano M, Kiritoshi S, Sonoda K, Kukidome D, Pestell RG, Brownlee M, Nishikawa T, Araki E.
    Biochem Biophys Res Commun; 2004 Feb 13; 314(3):817-23. PubMed ID: 14741709
    [Abstract] [Full Text] [Related]

  • 40. Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation.
    Xu X, Lu Y, Chen L, Chen J, Luo X, Shen X.
    Steroids; 2013 Sep 13; 78(9):813-22. PubMed ID: 23707573
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.